Skip to content

Impact of traditional ayurvedic drug Lipidom and Yogic Intervention vs Conventional Drug on Dyslipidemia.

TO ASSESS THE EFFICACY OF AYURVEDIC DRUG LIPIDOM AND YOGIC INTERVENTION VS. CONVENTIONAL DRUG IN PATIENTS WITH DYSLIPIDEMIA: AN OPEN LABEL, THREE ARM, RANDOMISED CONTROL TRIAL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2022/06/043085
Enrollment
114
Registered
2022-06-08
Start date
Unknown
Completion date
Unknown
Last updated
2024-07-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: E785- Hyperlipidemia, unspecified

Interventions

None listed

Sponsors

Patanjali Research Institute governed by Patanjali Research Foundation Trust
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1. Adult male and non-pregnant female population pre-diagnosed with dyslipidemia. 2. Subject should have TC, TG, LDL, HDL lab parameter range according to NCEP ATP III guideline. 3. BMI 18.5-35 kg/m2 4. Subject willingness to participate and sign the informed consent form and ready to comply with protocol measures.

Exclusion criteria

Exclusion criteria: 1. Uncontrolled diabetes mellitus 2. Medical history of unstable angina. 3. Myocardial infarction. 4. I patients is having active cardiac, hepatic, renal disease or have history of stroke within past three months. If patients having active malignant condition. 5. Pregnant/Lactating women

Design outcomes

Primary

MeasureTime frame
Change in laboratory parameters of lipid profile compared to baseline after 3 months of Ayurvedic drug lipidom intervention. Change in laboratory parameter of lipid profile compared to baseline after 3 months of yogic practices. Change in laboratory parameter of lipid profile compared to baseline after 3 months of conventional treatment.Timepoint: Day 0, week 12

Secondary

MeasureTime frame
Changes in quality of life, stress levels, lifestyle modification, and fatigue in patients with dyslipidemia. Treatment satisfaction and adherence for specific drug.Timepoint: Day 0, week 6, week 12

Countries

India

Contacts

Public ContactPriyanka Rani

Patanjali Yog Gram

principal.investigator@prft.in7302254793

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026